Markets:

Overview

News

Currencies

International

Treasuries

Redhill Biopharma Ltd. - American Depositary Shares (NQ:RDHL)

1.380 +0.020 (+1.47%)

Streaming Delayed Price Updated: 11:36 AM EST, Jan 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Redhill Biopharma Ltd. - American Depositary Shares

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

RedHill Biopharma Ltd Announces Potent Omicron Inhibition with RedHill's Opaganib

April 11, 2022

Oral opaganib's reported potent in vitro activity against Omicron adds to previously observed inhibition of Delta and other SARS-CoV-2 variants of concern that cause COVID-19; Testing conducted by The...

From RedHill Biopharma Ltd

Via AccessWire

64 Biggest Movers From Yesterday ↗

March 18, 2022

Gainers Kidpik Corp. (NASDAQ: PIK) shares surged 158.2% to settle at $4.75 on Thursday after the company announced a partnership with The Walt Disney Co. Cuentas Inc. (NASDAQ:...

Via Benzinga

RedHill, Kukbo Ink Oral Opaganib Licensing Pact For COVID-19 In South Korea ↗

March 15, 2022

Via Benzinga

Redhill Biopharma: Q4 Earnings Insights ↗

March 17, 2022

Redhill Biopharma (NASDAQ:RDHL) reported its Q4 earnings results on Thursday, March 17, 2022 at 07:00 AM. Here's what investors need to know about the announcement....

Via Benzinga

Earnings Scheduled For March 17, 2022 ↗

March 17, 2022

Companies Reporting Before The Bell • TransGlobe Energy (NASDAQ:TGA) is estimated to report earnings for its fourth quarter. • Ikena Oncology (NASDAQ:IKNA) is...

Via Benzinga

Redhill Biopharma's Earnings: A Preview ↗

March 16, 2022

Redhill Biopharma (NASDAQ:RDHL) is set to give its latest quarterly earnings report on Thursday, 2022-03-17. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

RedHill Biopharma's Upamostat Shows 100% Efficacy In Non-Hospitalized COVID-19 Patients ↗

March 01, 2022

RedHill Biopharma Ltd (NASDAQ: RDHL) has announced topline results from the Phase 2 part of the Phase 2/3 study of RHB-107 (upamostat) in non-hospitalized...

Via Benzinga

RedHill Biopharma's COVID-19 Antiviral Cuts Mortality By 70% In Remdesivir Treated Patients ↗

February 07, 2022

RedHill Biopharma Ltd (NASDAQ: RDHL) has announced results from two recently completed prespecified analyses from the oral opaganib Phase 2/3 study in hospitalized severe COVID-19.

Via Benzinga

18 Stocks Moving in Friday's Pre-Market Session ↗

January 14, 2022

Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) shares rose 17.6% to $0.8350 in pre-market trading after dropping around 9% on Thursday. NextPlay Technologies, Inc...

Via Benzinga

RedHill Biopharma's Oral COVID-19 Treatment Improves Median Time To Viral RNA Clearance ↗

January 13, 2022

RedHill Biopharma Ltd (NASDAQ: RDHL) announced new data from a prespecified analysis of all oral opaganib's Phase 2/3 study patients in COVID-19 patients. The...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 15, 2022

During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...

Via Benzinga

63 Biggest Movers From Yesterday ↗

December 31, 2021

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) shares surged 93.2% to close at $1.70 on Thursday. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

December 30, 2021

Gainers Kiora Pharmaceuticals (NASDAQ:KPRX

Via Benzinga

44 Stocks Moving In Thursday's Mid-Day Session ↗

December 30, 2021

Gainers Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) jumped 52.3% to $1.3396. Kiora Pharmaceuticals recently appointed David Hollander, MD, MBA, to its Board of Directors. Future...

Via Benzinga

RedHill Announces Additional Insider Buying

December 15, 2021

RALEIGH, NC and TEL-AVIV, ISRAEL / ACCESSWIRE / December 15, 2021 / RedHill Biopharma Ltd. (NASDAQ:RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that...

From RedHill Biopharma Ltd

Via AccessWire

Epigenetics, Psychedelics and Stem Cell Therapy are Topics of the Life Sciences Virtual Investor Conference Launching This Thursday ↗

December 14, 2021

Photo by Chris Montgomery on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial...

Via Benzinga

RedHill Biopharma's Talicia Recommended For H. Pylori Infection ↗

December 09, 2021

RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study revealing concerning rates of widespread, physician-directed prescribing of...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

December 09, 2021

Good morning, trader! It's time to kick off another busy day of trading with the biggest pre-market stock movers for Thursday!

Via InvestorPlace

RedHill Biopharma Ltd Announces Concerning Clarithromycin Rx Rates for H. pylori

December 09, 2021

RedHill Biopharma: Concerning Rates of Clarithromycin Prescribing for H. pylori, Despite Increasing Antibiotic Resistance, Uncovered in New Digestive Diseases & Sciences Publication Despite increasing...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

RedHill Biopharma Says Opaganib Mechanism Against COVID-19 Not Impacted By Omicron Mutations ↗

December 06, 2021

RedHill Biopharma Ltd (NASDAQ: RDHL) announced that opaganib's proposed mechanism of action is not impacted by spike protein mutations. Opaganib is expected to be...

Via Benzinga

Anxious World Waits As Covid Vaccine Makers Address Omicron Variant

December 07, 2021

Palm Beach, FL – December 7, 2021 – FinancialNewsMedia.com News Commentary There are many unknowns surrounding the new omicron Covid variant; there are early signs it’s more transmissible, but it’s not...

Via FinancialNewsMedia

RedHill Biopharma Ltd - Opaganib MoA Not Impacted by Omicron Mutations

December 06, 2021

Unique Mode of Action Opaganib works by targeting the human host cell rather than the virus itself and is therefore not expected to be impacted by spike protein mutations, providing a strong rationale...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

RedHill Biopharma's Talicia For Bacterial Infections Shows Efficacy Irrespective of Patient BMI ↗

December 02, 2021

RedHill Biopharma Ltd (NASDAQ: RDHL) has announced the publication of a new study of Talicia to treat H. pylori infection. The new publication, describing a ...

Via Benzinga

RedHill Biopharma Ltd Announces Talicia: Consistent Efficacy Irrespective of BMI

December 02, 2021

RedHill Biopharma Data Published in GastroHep Shows Consistent Efficacy of Talicia Irrespective of Patient BMI High Body Mass Index and obesity are known risk factors for H. Pylori eradication...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

RedHill’s Movantik Added To Medicare Formulary

December 01, 2021

RedHill Biopharma's Movantik® Added as Preferred and Unrestricted Brand To Major National Medicare Formulary Serving Millions of Americans Movantik® approved for inclusion as preferred and unrestricted...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout ↗

November 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Cumberland Gets FDA Approval For IV-Delivered Ibuprofen For Use In Pre-...

Via Benzinga

RedHill Reports 3Q/2021 Financial Results

November 30, 2021

RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial Results RedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against...

From RedHill Biopharma Ltd

Via AccessWire

Topics Intellectual Property Regulatory Compliance

Earnings Scheduled For November 30, 2021 ↗

November 30, 2021

Companies Reporting Before The Bell • Hello Gr (NASDAQ:MOMO) is estimated to report quarterly earnings at $0.31 per share on revenue of $573.63 million. • UP...

Via Benzinga

Earnings Preview For Redhill Biopharma ↗

November 29, 2021

Redhill Biopharma (NASDAQ:RDHL) is set to give its latest quarterly earnings report on Tuesday, 2021-11-30. Here's what investors need to know before the announcement. Analysts...

Via Benzinga

52 Biggest Movers From Friday ↗

November 22, 2021

Gainers Greenland Technologies Holding Corporation (NASDAQ: GTEC) shares surged 90.2% to close at $9.89 on Friday. Greenland Technologies highlighted the launch of second...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Redhill Biopharma Ltd. - American Depositary Shares (NQ:RDHL)

All News about Redhill Biopharma Ltd. - American Depositary Shares

Resources